ADPKD, Tolvaptan, and Nephrolithiasis Risk.

Patients with autosomal dominant polycystic kidney disease (ADPKD) have a higher risk of nephrolithiasis ([1][1]). When using unenhanced computed tomography, calculi can be identified in up to 25% of patients with ADPKD ([2][2]). Kidney stones in patients with ADPKD are usually composed of uric acid